BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr |
What is the latest Operating Profit of BAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹25 Cr |
How is Operating Profit of BAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | -3.80 | |
| Mar2024 | ₹31 Cr | 22.52 | |
| Mar2023 | ₹25 Cr | 5.30 | |
| Mar2022 | ₹24 Cr | -2.70 | |
| Mar2021 | ₹25 Cr | - | |
Compare Operating Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹119.8 Cr | 8% | 7.9% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 8% |
7.9% |
-12.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses